Pricing
  1. US-listed companies
  2. BIOLASE, INC
  3. Financials
  4. Cash from financing

BIOLASE, INC【BIOLQ】

Market cap
$36.6
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Dec 31, 202317+278.75%
Dec 31, 20225-84.63%
Dec 31, 202130+23.02%
Dec 31, 202024+127.12%
Dec 31, 201911-4.57%
Dec 31, 201811-48.03%
Dec 31, 201722+131.21%
Dec 31, 20169-9004.76%
Dec 31, 2015-0-100.22%
Dec 31, 201447+428.45%
Dec 31, 20139+467.48%
Dec 31, 20122-89.87%
Dec 31, 201115

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)